The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 17, 2024
Filed:
Aug. 20, 2020
Applicants:
Epizyme, Inc., Cambridge, MA (US);
Eisai R&d Management Co., Ltd., Tokyo, JP;
Inventors:
Heike Keilhack, Belmont, MA (US);
Brett Truitt, Cambridge, MA (US);
Yuta Suzuki, Tokyo, JP;
Tsukasa Murase, Tokyo, JP;
Futoshi Shikata, Tokyo, JP;
Assignees:
Epizyme, Inc., Cambridge, MA (US);
Eisai R&D Management Co., Ltd., Tokyo, JP;
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/20 (2006.01); A61K 9/00 (2006.01); A61K 9/28 (2006.01); A61K 31/5377 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5377 (2013.01); A61K 9/0053 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 9/2077 (2013.01); A61K 9/2095 (2013.01); A61K 9/2846 (2013.01); A61K 9/2893 (2013.01); A61P 35/00 (2018.01); A61K 9/2004 (2013.01);
Abstract
The present invention relates to pharmaceutical compositions comprising inhibitor(s) of human histone methyltransferase EZH2, and methods of cancer therapy using the EZH2 inhibitor(s).